| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Beone Medicines AG's insiders have reduced their positions by a net 31,028 shares worth roughly $11.3M. In the past 30 days, 0 insiders bought and 1 sold.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 397.9K | $141.25M | - | |
| Dir | 161.6K | $57.35M | - | |
| Other | 99.6K | $35.37M | - | |
| Dir | 83.7K | $29.72M | - | |
| Dir | 73.2K | $25.97M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | Julia Aijun Wang54 | Chief Financial Officer | Sell | 308 | $349.06 | $107,511.68 | -100% | +3.4% | -52.3% | |
| Jun 29, 2021 | Jane Huang81 | CMO, Hematology | Sale+OE | 1,925 | $354.97 | $683,323.00 | - | +5.6% | -54.6% | |
| Jun 28, 2021 | Howard Liang59 | CFO & Chief Strategy Officer | Sell | 446 | $365.00 | $162,790.00 | -100% | +5.4% | -53.9% | |
| Jun 28, 2021 | Lai Wang50 | Global Head of R& D | Sell | 455 | $362.48 | $164,929.95 | -100% | +5.4% | -53.9% | |
| Jun 18, 2021 | Howard Liang59 | CFO & Chief Strategy Officer | Sell | 486 | $325.89 | $158,383.46 | -100% | +19.7% | -58.9% | |
| Jun 18, 2021 | Lai Wang50 | Global Head of R& D | Sell | 802 | $331.15 | $265,583.18 | -100% | +19.7% | -58.9% | |
| Jun 18, 2021 | Xiaobin Wu52 | President, COO & Gm China | Sell | 1,156 | $330.93 | $382,550.57 | -100% | +19.7% | -58.9% | |
| Jun 18, 2021 | Jane Huang81 | CMO, Hematology | Sell | 469 | $325.66 | $152,733.04 | -100% | +19.7% | -58.9% | |
| Jun 10, 2021 | Timothy Yung-Cheng Chen | Director | Sale+OE | 6,000 | $351.67 | $2,110,017.89 | - | -2.9% | -58.2% | |
| Jun 7, 2021 | Lai Wang50 | Global Head of R& D | Sell | 656 | $354.26 | $232,392.33 | -100% | +0.7% | -55.1% |